JNP
Juniper Pharmaceuticals, Inc. Common Stock
JNP
JNP
Delisted
JNP was delisted on the 13th of August, 2018.
48 hedge funds and large institutions have $44.1M invested in Juniper Pharmaceuticals, Inc. Common Stock in 2018 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 18 increasing their positions, 17 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
14% less capital invested
Capital invested by funds: $51.2M → $44.1M (-$7.15M)
Holders
48
Holding in Top 10
1
Calls
$821K
Puts
–
Top Buyers
| 1 | +$1.07M | |
| 2 | +$797K | |
| 3 | +$766K | |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
+$666K |
| 5 |
AIC
AWM Investment Company
New York
|
+$435K |
Top Sellers
| 1 | -$1.61M | |
| 2 | -$613K | |
| 3 | -$558K | |
| 4 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
-$459K |
| 5 |
Morgan Stanley
New York
|
-$431K |
